reports
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (B...
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury Company continues pioneering research on BCI-enabled system to restore mobility after spinal cord injury EINDHOVEN, The Netherlands, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), announces another successful implant of its investigational ARC-BCI™ System to restore ...
ONWARD® Medical annonce le troisième implant de son système d'interfac...
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière La société poursuit ses recherches novatrices sur un système activé par une interface cerveau-machine (BCI) pour restaurer la mobilité après une lésion de la moelle épinière EINDHOVEN, Pays-Bas, 19 sept. 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), société de technologie médicale à l’origine de thérapies* innovantes pour restaurer le mouvement, la fonction et l’indépendance chez les personnes atteintes de lési...
D`ieteren Group: 2 directors
Two Directors at D`ieteren Group bought 4,100 shares at between 200.880EUR and 221.000EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
- Sharad Kumar S.P
Holdings Report - August 2024 KBCS Holdings Universe Up 0.5% Thanks To...
1M Performance - Absolute: During July'24 (1M period), the KBCS Holdings Universe posted a return of 0.5% which was mainly driven by multi-asset holdings (+1.7%) while single-asset holdings posted a negative return of -1.3%. The 3 top performers during the period were HAL Trust (+5.1%), Texaf (+2.9%), and The Infrastructure Company (TINC, +9.6%) while the 3 worst performers were Brederode (-2.8%), Solvac (-5.3%), and Whitestone Group (-7.2%). YTD Performance - Relative: On a YTD basis (as of A...
GBLB GROUPE BRUXELLES LAMBERT SA
HAL HAL TRUST
DIE D'IETEREN SA
SOF SOFINA SA
SOLV SOLVAC S.A.
GIMB GIMV NV
QFG QUEST FOR GROWTH
ACKB ACKERMANS & VAN HAAREN NV
TUB FINANCIERE DE TUBIZE S.A.
HEIO HEINEKEN HOLDING N.V.
KBCA KBC ANCORA SCA
TEXF TEXAF
BREB BREDERODE S.A.
TINC TINC COMM. VA
ROCK WHITESTONE GROUP
- Michiel Declercq
D'Ieteren Shareholder shift & extraordinary dividend in focus after go...
D'Ieteren reported a good set of 1H24 results, with the adj. PBT (gs) up 6.4% to € 586m (kbcse: € 572m, css: € 546m), while FCF (gs) improved materially to € 540m (1H23: € 187m). The group also confirmed its outlook. More important was the shareholder reorganisation, with Nayarit to acquire 16.7% from SPDG. Secondly, D'Ieteren announced the proposal of an extraordinary dividend of € 74 per share. Buy and € 260 TP reiterated.
- ING Helpdesk
- Jacob Mekhael
- Thomas Vranken
Onward Medical 1H24 update holds no surprises, ARC-EX FDA approval in ...
Onward reported its 1H24 business update, which holds no surprises, and we note that the company reiterated the timeline for the key milestone of obtaining FDA clearance to launch its ARC-EX System in the US in 4Q24. Onward's cash runway is until spring 2025, and access to tranches from its € 52.5m debt agreement could unlock funding beyond this timeline, and allow the company to show early commercial traction for ARC-EX. All in all, a positive update, and as such, we maintain our € 9.3 TP and B...
- Jacob Mekhael
- Michiel Declercq
- Wim Lewi
- Wim Lewi
Shurgard Big add-on acquisition in Germany
Shurgard announced the acquisition of Prime Self-Storage in Germany for EUR 100.0m (asset deal) that will add 24 kSqm at 7% yield. In our recent company note, we highlighted that additional M&A would continue during the Lock'nStore integration period till 2026. However, we counted on NL and FR for additions as GE already absorbed the Top Box's (Oct. 23) and the Pickens portfolio (Mar. 24). Now, SHUR reinforces its nr2 position in GE and will achieve the top spot by 2026 at the latest. Myplace...
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business...
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Up-LIFT Study results published in Nature Medicine De Novo application submitted to FDA to obtain clearance to market the investigational ARC-EX® System in the United States Up to EUR 52.5M in growth financing obtained from US-based Runway Growth Capital Several additional milestones achieved with the investigational ARC-BCI™ System, leveraging brain-computer inte...
- ING Helpdesk
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Michiel Declercq
- Sharad Kumar S.P
- Thibault Leneeuw
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
Dynamic Top Pick List Update September 2024 –Cofinimmo & Kinepolis in;...
In this September update of our Dynamic Top Pick List we make 4 changes. •We include Cofinimmo in our Dynamic Top Pick List after our recent upgrade from Accumulate to Buy. We expect the name to outperform in a decreasing interest rate environment given its relatively high leverage and cheap valuation. We also believe the risk of a dilutive equity raise eased when the FY24 capex decreased from € 320m to € 250m. The management stays disciplined in its capex program and continues to focus on asse...
BEKB BEKAERT SA
ABN ABN AMRO BANK NV DEPOSITARY RECEIPTS
FAGR FAGRON SA
EVS EVS BROADCAST EQUIPMENT SA
XIOR XIOR STUDENT HOUSING N.V.
SOLB SOLVAY SA
COFB COFINIMMO SA
DIE D'IETEREN SA
SOF SOFINA SA
VAN VAN DE VELDE S.A.
IBAB ION BEAM APPLICATIONS SA
ACKB ACKERMANS & VAN HAAREN NV
CPINV CARE PROPERTY INVEST SA
KIN KINEPOLIS GROUP NV
TINC TINC COMM. VA
FUR FUGRO NV
SYENS SYENSQO
- ING Helpdesk
- Jacob Mekhael
- Sharad Kumar S.P
- Wim Hoste
- Wim Lewi
- Jacob Mekhael
- Thomas Vranken
Onward Medical $1m grant to study brain-computer interface platform
Onward announced a $ 1.1m grant from the Christopher & Dana Reeve Foundation to support expansion of an ongoing early clinical feasibility study to explore the use of a brain-computer interface (BCI) to restore thought-driven use of the hands and arms after SCI. This technology has the potential to revolutionise the treatment of SCI, and the grant will enable Onward's research partner to generate data in additional patients, which could provide validation for Onward's approach in this emerging a...
- Wim Lewi
Shurgard Model update as LnS integration kicks off
One can't bake an omelette without breaking eggs. Shurgard aims to be a market leader in each of its markets and cracking the UK will take some pain. We believe the relative high valuation in the past was justified as SHUR delivered consistent above market growth from its platform through its development pipeline. Market share and occupancy% are 2 important levers for a platform's profitability. In this note, we integrated the Lock'nStore (LnS) pipeline into our model. The own developments and ...
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundati...
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System Grant will enable ONWARD Medical, CEA-Clinatec and .NeuroRestore to evaluate the use of the ONWARD ARC-BCI™ System to restore thought-driven movement of the hands and arms after spinal cord injury (SCI) EINDHOVEN, the Netherlands, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord i...
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business U...
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update Company to provide more detailed commercial plans for its ARC-EX System EINDHOVEN, The Netherlands, Aug. 27, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that it will host a webcast to discuss its Half-Year 2024 business highlights. The webcast will be held on September 10, 2024, at 2:00PM CET / 08:00AM ET....
- Oliver Metzger
- Roy Külter
- Florent Laroche-Joubert
- Gerardo Ibanez
- Roy Külter
Shurgard : A brisk H1 operating performance in line, and a very good S...
>Adjusted EPRA earnings/share at € 0.80 (-1.4% y-o-y CER) vs consensus at € 0.83e - Shurgard’s H1 24 publication (revenues at € 189.3m, giving growth at current scope and constant forex at +8.2%) reflects the maintained operating performance and solid current and future growth.Shurgard continues to benefit overall from good rental pressure with a same-store occupancy rate at 89.5% (-500bp decline y-o-y) in H1 24, above Q2 at 89.8% vs 89.2% in Q1 and average in-pl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.